What’s New

We share news about new product features, our thoughts on recent developments at MedaSystems or in the industry at large. Scroll down for a chronological view, or jump to posts using the categories to the left.

Expanded Access Programs, Clinical Operations, Patient Access Strategy Aimee Caton Expanded Access Programs, Clinical Operations, Patient Access Strategy Aimee Caton

Build vs. Buy in Expanded Access Programs: Finding the Right Balance for Patient Access

As expanded access and managed access programs become increasingly important components of patient access strategy, biopharmaceutical companies face a critical question: which capabilities should be developed internally, and which are best supported through external expertise and technology partners?

Read More
Expanded Access Programs, Clinical Operations, Compassionate Use Aimee Caton Expanded Access Programs, Clinical Operations, Compassionate Use Aimee Caton

How Expanded Access Programs Are Evolving in 2026

For patients facing serious or life-threatening conditions, waiting for full regulatory approval of a promising therapy is often not an option. Expanded Access Programs (EAPs), sometimes referred to as compassionate use programs, have long provided a regulatory pathway for patients to receive investigational treatments outside of clinical trials.

Read More